BioTrinity 2024

Published on March 19, 2024

Meet with Abzena at BioTrinity 2024 on April 23–24 in London.

Jonathan Cruickshank, Head of EU/ROW Sales – R&D and Manufacturing, and Roger Bowie, VP of Business Development, will both be in attendance, and are looking forward to meeting with current and future contacts to discuss how Abzena can support all your needs for Biologics and Bioconjugates.

Schedule a meeting now.



Event Information:

BioTrinity 2024

April 23-24, 2024

Venue 133 Houndsditch, London

 

The post BioTrinity 2024 appeared first on abzena.

Continue reading on website
Other news

Outsourcing Pharma Roundtable: What are the global pharma giants’ goals at DCAT 2024?

March 19, 2024
In Outsourcing Pharma’s latest roundtable discussion, our CSO, Dr Campbell Bunce, shares insights into Abzena’s plans and goals at DCAT Week in NYC this March.  DCAT Week is one of the largest pharmaceutical industry conferences that’s focused on future trends, investor insights, and community awareness.Campbell shares: “We would like to come away from DCAT Week with a better, more informed sense

The Medicine Maker: Pool Power

March 19, 2024
In The Medicine Maker’s latest issue, our VP of Cell Line Development, Simon Keen, tackles the burning question: Why is the stable pools approach attracting more attention in the cell line development space? in an article appropriately named, “Pool Power”.At the core of biopharmaceutical production is cell line development (CLD). CLD stands as the foundation upon which the success of biologics is